Blood Pressure News
-
Updated 1 hour, 11 minutes ago
Standard physicals are, well, pretty standard. During a visit geared more toward detecting disease than preventing it, your doctor makes you cough and checks your numbers. If there’s an abnormality -- your blood pressure has spiked or your liver enzymes are elevated -- it’s your schedule that suffers as you’re shuttled between specialists.
-
Updated 1 hour, 23 minutes ago
Talk to people in Oregon about health care for long and eventually you will be asked something like this: “You’ve heard the air conditioner story, right?”
-
Roche Holding AG’s experimental leukemia drug shrank tumors in more patients when added to chemotherapy, according to study results that may aid the company in expanding its line of blood-cancer treatments.
-
Bristol-Myers Squibb Co., pouring resources into new immune system-based cancer drugs, said it also plans to expand development of treatments for congestive heart failure and fibrosis.
-
Lowering sodium intake, a drumbeat of doctors’ efforts to improve patient health, may have the opposite effect if taken to the extreme, scientists said.
-
Adcock Ingram Holdings Ltd., South Africa’s largest supplier of hospital products, may gain a further 12 percent from yesterday’s 30-month high after it got takeover offers, according to JPMorgan Chase & Co.
-
Witnesses for Intuitive Surgical Inc. testified that heart disease, not a failed robotic procedure, killed a patient whose widow is suing the company over claims that overly aggressive marketing caused surgical errors.
-
Aveo Pharmaceuticals Inc. failed to win the backing of U.S. regulatory advisers for its lead product candidate, a kidney cancer drug, after the panelists questioned whether it was as effective as existing treatments.
-
George Jones, the country-music singer who overcame alcohol and drug addiction, bankruptcy and broken marriages to have more hit records than any other artist, has died. He was 81.
-
Aveo Pharmaceuticals Inc.’s lead product candidate, a kidney cancer drug, may need another clinical trial to assess the benefit, U.S. regulators said. Aveo shares dropped in early trading.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page